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Foot-and-mouth disease virus (FMDV) particles lose infectivity due to their disassembly at pH values
slightly below neutrality. This acid-dependent disassembly process is required for viral RNA release inside
endosomes. To study the molecular determinants of viral resistance to acid-induced disassembly, six FMDV
variants with increased resistance to acid inactivation were isolated. Infection by these mutants was more
sensitive to drugs that raise the endosomal pH (NH4Cl and concanamycin A) than was infection by the parental
C-S8c1 virus, confirming that the increase in acid resistance is related to a lower pH requirement for
productive uncoating. Amino acid replacement N17D at the N terminus of VP1 capsid protein was found in all
six mutants. This single substitution was shown to be responsible for increased acid resistance when intro-
duced into an infectious FMDV clone. The increased resistance of this mutant against acid-induced inactiva-
tion was shown to be due to its increased resistance against capsid dissociation into pentameric subunits.
Interestingly, the N17D mutation was located close to but not at the interpentamer interfaces. The mutants
described here extend the panel of FMDV variants exhibiting different pH sensitivities and illustrate the
adaptive flexibility of viral quasispecies to pH variations.
Foot-and-mouth disease virus (FMDV) is the causative
agent of a highly contagious disease of cloven-hoofed animals
(23) that poses important restrictions for international trading
(11, 45, 49, 51). FMDV is the type species of the Aphthovirus
genus within the family Picornaviridae (20). Its genome is com-
posed of a single RNA molecule of positive polarity and about
8.5 kb in length. Like other RNA viruses, FMDV populations
consist of complex and dynamic distributions of variants
termed quasispecies (17) and exhibit a high potential for vari-
ation and adaptation, reflected in seven serotypes and multiple
antigenic variants (18, 50).
FMDV RNA is protected by a capsid that comprises 60
copies of each of the four structural proteins (VP1 to VP4)
arranged in an icosahedral lattice of 12 pentameric subunits,
which constitute intermediates of capsid assembly and disas-
sembly (56). After attachment to the host cell using a variety of
receptors, such as different v integrins, heparan sulfate gly-
cosaminoglycans (for some tissue culture-adapted variants), or
other not-well-characterized molecules (2, 3, 5, 25–28, 46),
FMDV particles are internalized by endocytosis mediated by
clathrin (for viruses using integrin receptor) or caveolae (in the
case of variants using heparan sulfate). In both cases, FMDV
particles are delivered to early endosomes for capsid disassem-
bly and viral genome release (7, 29, 33, 43, 44).
FMDV particles display extreme acid lability, being inacti-
vated at pH values slightly below neutrality (12, 35, 41, 55). The
pH sensitivity of FMDV is required for capsid disassembly
triggered by acidification inside endosomes, allowing release of
the RNA genome within infected cells (4, 9, 10). An acid-labile
capsid is not a general feature of picornaviruses; in fact, it is
only shared by other aphthoviruses, cardiovirus, and rhinovirus
(41). Histidine residues located close to the interpentameric
interface act as pH sensors, triggering FMDV capsid dissoci-
ation after their protonation at the acidic pH inside the endo-
some and the establishment of electrostatic repulsions between
capsid subunits (1, 12, 19, 55). Capsid disassembly of FMDV
into pentameric intermediates is accomplished with the release
of the internal VP4 protein. Since VP4 is a highly hydrophobic
and myristoylated protein, its exposure could facilitate endo-
somal membrane permeabilization and viral RNA release
from the endosome (6, 14, 15, 30).
Although the role of endosomal acidification was related to
FMDV uncoating more than 20 years ago (4, 9, 10), the mo-
lecular determinants that mediate FMDV uncoating at acidic
pH have not been fully elucidated. The isolation and charac-
terization of mutants displaying alterations in the uncoating
mechanism should provide a useful tool for the study of this
process. Along this line, FMDV variants with increased acid
lability have been previously characterized (35); an FMDV
variant with increased resistance to acid inactivation was also
isolated (54), although the molecular basis for this phenotype
was not elucidated. In the present study, we have addressed the
study of the molecular determinants associated with viral re-
sistance to acid inactivation as an approach to provide a deeper
insight into the structural bases for FMDV uncoating. To this
end, six FMDV variants with increased resistance to acid in-
activation were isolated. Infection by these mutants displayed
increased sensitivity to drugs that raise endosomal pH, con-
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firming that the increase in acid resistance was related to a
lower pH requirement for productive uncoating within host
cells. A single amino acid substitution located at the N termi-
nus of VP1 protein, common in all mutants isolated, was found
to be responsible for the increased resistance to acid inactiva-
tion, which correlated with an increased resistance to acid-
induced dissociation into pentameric subunits. These results
extend the range of pH sensitivities of FMDV mutants (35)
and illustrate the adaptive flexibility of viral quasispecies to
environmental changes, in this case related to pH variations.
MATERIALS AND METHODS
Cells, viruses, infections, and virus titrations. The origin and culture proce-
dures for BHK-21 cells have been described (32, 33). C-S8c1 is a biological clone
of a type C FMDV isolate (48). c2 is a FMDV variant with increased resistance
to endosomal acidification blockage (35). Procedures for infections and virus
titration in semisolid agar medium were as described previously (33–35, 48).
Radioactive labeling and purification of virions. A previously published pro-
cedure (37, 39) was followed. Briefly, FMDV virions (C-S8c1 and mutants) were
metabolically labeled with [35S]methionine (EasyTag Express protein labeling
mix; Perkin-Elmer) during infection of BHK-21 cells. The total virus produced
was centrifuged through a cushion of 20% sucrose in TNE buffer (10 mM
Tris-HCl [pH 7.5], 0.1 M NaCl, 1 mM EDTA) in an AH-625 rotor (Sorvall) at
25,000 rpm for 2.5 h at 4°C. The viral pellet was resuspended in TNE buffer and
centrifuged in 7.5 to 30% sucrose density gradients in the same buffer at 37,000
rpm for 1 h at 4°C in an SW40 rotor (Beckman). The fractions containing full
virions (sedimentation coefficient, 140S) were pooled and extensively dialyzed
against phosphate-buffered saline (PBS). The integrity of virions was analyzed in
7.5 to 45% sucrose density gradients at 18,000 rpm for 18 h at 4°C in an SW40
rotor (Beckman Instruments).
Acid-induced inactivation assays. A modification of a previously reported
procedure was followed (30, 35). Briefly, equal amounts (10 l containing 106
PFU) of the virus tested were mixed with 300 l of PBS solutions (50 mM NaPO4
and 140 mM NaCl) of different pHs for 30 min at room temperature. The
solution was neutralized by adding 100 l of 1 M Tris (pH 7.6), and the remain-
ing PFU counts in each sample were determined by plaque assay on BHK-21
cells. The number of PFU developed was determined and is expressed as the
percentage of infectivity compared to that obtained using PBS at pH 7.4 or 7.6.
Acid-induced disassembly assays. Aliquots (100 l) of 35S-labeled purified
virions were mixed with 300 l of PBS solutions (50 mM NaPO4 and 140 mM
NaCl) of different pHs (i.e., pH 5.6 to 7.2) for 30 min at room temperature. The
solution was neutralized by adding 100 l of 1 M Tris (pH 7.6). Subsequently, the
solution was loaded in 7.5 to 45% sucrose density gradients and centrifuged at
4°C in an SW40 rotor (Beckman Instruments) at 18,000 rpm for 18 h. The
gradients were fractionated in 0.5-ml aliquots, and the radioactivity was deter-
mined by using a liquid scintillation counter. Values were expressed as a per-
centage of the amount of full virions (sedimentation coefficient, 140S) obtained
at different pHs, relative to the amount obtained at pH 7.2.
Thermal inactivation assays. A previously published procedure was followed
(37). Briefly, equal amounts of infectious virions (107 PFU) were incubated at
42 or 50°C during 0, 30, 60, or 120 min. At these times, virus samples were frozen,
and the remaining virus titer was determined by plaque assay.
Endosomal acidification blockage. Inhibition of endosomal acidification with
NH4Cl was performed as described previously (4, 33). Briefly, cells were treated
for 1 h prior to infection with 25 mM NH4Cl in culture medium supplemented
with 25 mM HEPES at pH 7.4, and the drug was maintained throughout the rest
of the assay. Alternatively, cells were pretreated with 1 M concanamicin A
(ConA) 30 min prior to infection, and the drug was only maintained during the
first infection hour (7, 33). Control samples were treated in parallel with the
same amount of drug solvent (dimethyl sulfoxide).
Viral RNA extraction, cDNA synthesis, and DNA sequencing. Viral RNA was
extracted from supernatants of infected cell cultures by using TRI reagent
(Sigma). cDNA synthesis by reverse transcription, amplification by PCR, and
DNA sequencing have been previously described (35). DNA sequences were
confirmed by at least two independent sequencing reactions. Nucleotide posi-
tions correspond to those of the FMDV C-S8c1 isolate (52).
Infectious clone manipulation, in vitro transcription, and transfection of
BHK-21 cells. Plasmid pMT28 (21), which contains the full-length cDNA of
FMDV C-S8c1, was used to construct plasmid pMT28-VP1 N17D bearing the
nucleotide substitution A3256G found in the capsid coding region of the six
FMDV mutants with increased resistance to acid induced inactivation (Table) 1.
To this end, cDNA obtained from reverse transcription of RNA extracted from
virus m6 was digested with SfiI and AvrII (New England Biolabs), and the
resultant fragment purified by agarose gel electrophoresis was ligated into
pMT28 vector digested with the same restriction endonucleases using T4 DNA
ligase (Promega). Amplification of plasmid DNA was performed in Escherichia
coli DH5. Nucleotide sequences of infectious DNA clones were confirmed by
DNA sequencing as described above. Transcription of viral RNA from infectious
clones and transfection of cells with in vitro-synthesized viral RNA was per-
formed as reported elsewhere (35).
Competition experiments. A modification of a previously published procedure
(40) was followed. Briefly, a mixture containing equal amounts of each pair of
competing viruses derived from infectious clones—initial multiplicity of infection
(MOI) of 0.1 (0.05 for each virus)—was treated with pH 7.6 or pH 6.0 buffers,
neutralized, and used to infect a 35-mm-diameter tissue culture dish. When a
complete cytopathic effect was observed, the viruses were harvested. Viral sus-
pensions (50 l) were incubated at pH 7.6 or 6.0, neutralized, and used to infect
fresh cell monolayers. These cycles of pH treatment, infection, and harvest were
repeated up to four times in triplicate. Viral RNA was extracted, and the cDNA
encoding VP1 protein was synthesized and sequenced. The proportions of the
competing genomes were estimated from the chromatograms as a ratio of the
integrated areas of each nucleotide under each peak of mutated position (40).
TABLE 1. Mutations found in the capsid coding regions of FMDV mutants with increased resistance to acid induced inactivation selected
after two serial acid treatments
Genomic region
Mutation(s) found in viral populationa




VP3 A2576T* A2576T* A2576T* A2576T* A2576T*
D9V D9V D9V D9V D9V
G3000A
T3117C T3117C T3117C T3117C T3117C T3117C T3117C
VP1 A3256G A3256G A3256G A3256G A3256G A3256G
N17D N17D N17D N17D N17D N17D
C3750T
C3390*
a The nucleotide position in the C-S8c1 genome (52) and the substitution found are indicated. For nonsynonymous substitutions, amino acid replacements are
indicated in boldface. *, nucleotide mixture at this position between mutant and base in C-S8c1. See the text for details.
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Molecular graphics. The atomic coordinates of FMDV C-S8c1 (31) and the
programs RasMol (47) and Pymol (DeLano Scientific, Inc.) were used to locate
the mutated amino acid residues on the capsid structure (35).
RESULTS
Isolation of FMDV mutants with increased resistance to
acid inactivation. Infectious FMDV mutants with increased
acid resistance were isolated by biological cloning after acid
treatment. About 106 PFU of C-S8c1 were incubated 30 min at
room temperature in PBS at pH 6.0 or 7.4 (control) and then
neutralized. These samples were used to infect BHK-21 cell
monolayers in semisolid agar medium. After 48 h, cells in-
fected with samples treated at pH 6.0 showed approximately
0.0029  0.0005% (selection frequency of 2.9  105) of the
number of plaques observed in control cells. The viruses re-
covered from six lysis plaques were amplified by infection in
liquid medium (first passage) and subjected to a second treat-
ment with pH 6.0 and subsequent amplification in liquid me-
dium.
The viral populations obtained, termed mutants m1 to m6,
were used for further experiments. The six mutants analyzed
showed a decreased acid sensitivity compared to that of the
parental virus C-S8c1 (Fig. 1A). Thus, relative to the drastic
loss of infectivity observed (about 5 orders of magnitude) upon
pH 6.0 treatment of C-S8c1, mutants m2 to m6 showed an
infectivity reduction of only about 1 order of magnitude, which
was even lower for mutant m1. When incubation was per-
formed at pH 5.0, an infectivity reduction of about 5 orders of
magnitude was observed for mutants m1 to m6, whereas no
C-S8c1 PFU were recovered (Fig. 1A), confirming the in-
creased resistance of these mutants to acid-induced inactiva-
tion of infectivity.
A detailed analysis of the sensitivity to pH values from 6 to
7.5 (Fig. 1B) confirmed that mutants m1 to m6 displayed in-
activation profiles that are shifted to lower pH values relative
to that exhibited by C-S8c1. When pH50 values (defined as the
pH value leading to a 50% loss of infectivity [35]) were calcu-
lated, viruses m1 to m6 displayed very similar values (6.07,
6.15, 6.11, 6.15, 6.22, and 6.11, respectively). In the case of
C-S8c1 the pH50 value was 6.58, as previously reported (35).
Increased acid sensitivity correlates with higher sensitivity
to endosomal acidification blockage. FMDV uncoating leading
to productive infection is triggered by acidification inside en-
dosomes where viral particles are delivered (4, 7, 29, 33). Thus,
infection by FMDV particles with increased acid lability dis-
plays higher resistance to the endosomal acidification blockage
induced by different drugs such as NH4Cl and ConA (35).
These drugs were used to study whether an opposite effect was
observed with the acid-resistant mutants. Compared to C-S8c1,
mutants m1 to m6 showed, as expected, an increased sensitivity
to NH4Cl (Fig. 2A) and ConA treatment (Fig. 2B). In these
experiments, mutant c2, which encodes a capsid with increased
acid lability that confers resistance to endosomal acidification
inhibition (35), was included as a control. These results indi-
cate that the higher resistance to acid inactivation shown by
these mutants is related to an increased sensitivity to drugs that
raise the endosomal pH.
Analysis of mutations in the capsid-coding regions of acid-
resistant FMDV mutants. To identify the genotypic changes
responsible for the increased resistance to acid inactivation,
the complete capsid coding regions of mutants m1 to m6 and
FIG. 1. Resistance to acid-induced inactivation of FMDV mutants
selected after pH 6 treatment. (A) Equal PFU amounts of the different
viruses were treated with acid buffers (pH 6.0 and 5.0) or pH 7.4 as a
control. The samples were then neutralized and plated on BHK-21
monolayers. (B) Acid sensitivity profiles of FMDV mutants selected
after pH 6 treatment. Infectivity was calculated from experiments
performed as in panel A as the percentage of PFU recovered at each
different pH relative to that obtained at pH 7.5.
FIG. 2. Sensitivity to endosomal acidification blockage of FMDV
mutants resistant to acid pH inactivation. (A) Sensitivity to NH4Cl
treatment. Monolayers of BHK-21 cells treated or not treated with 25
mM NH4Cl were infected with the mutants and the parental virus
C-S8c1 (MOI of 0.5). FMDV mutant c2 with increased resistance to
endosomal acidification blockage (35) was also included. Virus yield
was determined 8 h postinfection. (B) Sensitivity to ConA treatment.
Monolayers treated or not with ConA (1 M) were infected as de-
scribed for panel A.
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of the parental population C-S8c1 were sequenced and com-
pared. Nucleotide and amino acid replacements found in vi-
ruses selected after two cycles of acid treatment and selection
are shown in Table 1. Remarkably, all mutants showed a com-
mon nucleotide substitution A3256G leading to amino acid
replacement VP1 N17D. Viruses m1 to m5 displayed also
various degrees of nucleotide mixture at position 2576 between
A (the nucleotide present in C-S8c1 sequence) and T (leading
to amino acid replacement VP3 D9V); the A/T % values were
as follows: m1, 53/47; m2, 28/72; m3, 68/32; m4, 78/21; and m5,
81/19. Virus m1 also exhibited an additional dominant nonsyn-
onymous nucleotide substitution T1996C responsible for VP2
F34L amino acid replacement. The rest of the nucleotide sub-
stitutions found were synonymous.
The nucleotide substitution leading to replacement VP1
N17D was shown already imposed in all six viral progenies
from cells infected with the virus recovered after the first cycle
of acid treatment and selection (first passage). Such imposition
was not observed for substitutions responsible for replace-
ments VP2 F34L in virus m1 (present at ca. 60%) and VP3
D9V, for which only traces (lower than 5%) were detected in
viruses m1 to m5.
None of the amino acid replacements selected involved in-
variant residues in the FMDV capsid (8). Replacement VP1
N17D found in viruses m1 to m6 affected a residue located at
the N terminus of VP1 protein, within an internal region of the
capsid, not far from the interpentamer interfaces (Fig. 3A).
This amino acid replacement produced a disruption of a hy-
drogen bond between VP1 N17 and VP4 G78 and was located
close to VP3 H143, which has been implicated in acid-induced
capsid disassembly (1, 19, 55) (Fig. 3B). Residue VP3 9 was
located at the outer surface of the capsid close to the capsid
pore (5-fold symmetry axis), and residue VP2 34 was located at
the internal surface of the capsid. Taken together, these results
suggest that an internal capsid amino acid replacement (VP1
N17D) was responsible for the acid-resistant phenotype of
viruses m1 to m6.
Amino acid substitution VP1 N17D confers increased resis-
tance to acid-induced inactivation of FMDV. To test whether
amino acid replacement VP1 N17D is sufficient to confer re-
sistance to acid induced inactivation, a plasmid carrying the
mutation responsible for this replacement was derived from
the infectious clone pMT28, which encodes the complete
genomic sequence of FMDV C-S8c1. The consensus nucleo-
tide sequence of the capsid-coding region of the virus derived
from the modified infectious clone (mutant VP1 17D) was
determined and compared to that of the virus derived from the
nonmutated, parental infectious clone pMT28 (C-S8c1). The
only nonsynonymous nucleotide replacement found was that
leading to replacement VP1 N17D (data not shown). Viruses
derived from the mutated and the parental infectious clones
were tested in acid-induced inactivation assays (Fig. 4). A sig-
nificant increase in the acid resistance was observed for mutant
VP1 N17D compared to C-S8c1. Virus VP1 N17D displayed a
FIG. 3. Location on the structure of the C-S8c1 capsid (31) of amino acid residues found to be substituted in FMDV mutants with increased
resistance to acid inactivation. (A) Outside and inside schematic views of a pentameric subunit in the capsid are shown. VP1 is green, VP2 is
magenta, VP3 is cyan, and VP4 is yellow. (B) Close-up view of the region boxed in panel A showing relevant neighbor amino acids to the VP1
N17D position (red). VP4 G78 establishes a hydrogen bond with N17 which should be disrupted upon N17D amino acid replacement, and VP3
H143 is implicated on an acid pH-sensing mechanism for FMDV uncoating. See the text for details.
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pH50 value of 6.25 (very close to the pH50 values for viruses m2
to m6), whereas the pH50 value determined for C-S8c1 virus
derived from the parental infectious clone was 6.62. These
results confirm that amino acid replacement VP1 N17D is
responsible for the increased resistance to acid inactivation
phenotype.
The increased resistance of mutant VP1 N17D against acid-
induced inactivation is due to its increased resistance against
capsid dissociation. To investigate whether the increased re-
sistance of mutant VP1 N17D to biological inactivation is re-
lated to an impaired dissociation into subunits, virions of
C-S8c1 and the VP1 N17D mutant were radiolabeled and
purified through sucrose gradients. Similar amount of virions
(sedimentation coefficient, 140S) were obtained in both cases.
The viruses were then incubated at different pHs for a defined
amount of time and subjected to analytical sedimentation anal-
ysis to determine the amount of intact virions remaining after
the treatment. The results (Fig. 5) show that the VP1 N17D
mutant virion is substantially more resistant than the parental
C-S8c1 virion to acid-induced dissociation of the capsid into
pentameric subunits. Their respective pH50 values for dissoci-
ation (about 6.3 and 6.6, respectively) were very similar to their
pH50 values for inactivation of infectivity (see above), and their
dissociation and inactivation curves overlapped to a large ex-
tent. Thus, the increased resistance of mutant VP1 N17D to
acid-induced inactivation is due to its increased resistance to
capsid dissociation into pentameric subunits.
Biological fitness of an acid-resistant FMDV virion. Viruses
recovered from infectious clones were tested in competition
experiments performed at different pHs (7.6 and 6.0). Equal
PFU amounts of C-S8c1 and VP1 N17D viruses were mixed
(initial MOIs of 0.1 [0.05 for each virus]), incubated at pH 7.6
(control) or 6.0, and used to infect BHK-21 cells. Viruses
recovered from these infections were harvested, incubated
again at pH 7.6 or 6.0, and further passaged. Approximate
percentages of competing genomes during the four serial pas-
sages analyzed were determined (Fig. 6). In three independent
experiments performed at pH 7.6, a similar proportion of the
competing genomes (ca. 50%) was observed along the four
passages. Conversely, in each of the three independent exper-
iments performed at pH 6.0, mutant VP1 N17D was already
dominant in the first passage (ca. 90%), and its proportion
progressively increased during passages up to values close to
100%. These results show that replacement VP1 N17D, re-
sponsible for increased resistance to acid inactivation, confers
a selective advantage in serial passages after incubation at low
pH (6.0), whereas it did not drastically alter viral fitness when
incubations were performed at a neutral pH. (pH 7.6).
Amino acid substitution VP1 N17D also confers increased
resistance to heat inactivation of FMDV. To continue the
characterization of the physicochemical alterations caused by
replacement VP1 N17D, the effect of high temperature on the
infectivity of C-S8c1 and VP1 17D viruses was analyzed. Rel-
FIG. 4. The single amino acid substitution N17D in VP1 is respon-
sible for increased acid resistance in FMDV mutants. Acid sensitivity
of viruses C-S8c1 (derived from infectious clone pMT28) or VP1 D17
(a derivative carrying the mutation responsible for replacement VP1
N17D). Equal PFU amounts of the different viruses were treated with
acid buffers, and samples were neutralized and plated. Infectivity was
calculated as the percentage of PFU recovered in BHK-21 cells rela-
tive to the obtained at pH 7.6.
FIG. 5. pH-induced disassembly of FMDV virions. The remaining
percentage of intact virions (sedimentation coefficient, 140S) is repre-
sented as a function of the pH of the buffer, relative to the amount of
intact virion at a pH of 7.2 (taken as 100%). Mutant virions (VP1
N17D, ) and the nonmutated control virions (pMT28 [C-S8c1], f)
were radioactively labeled, purified, and assayed in parallel as de-
scribed in Materials and Methods. The average values and error bars
corresponding to two independent measurements are indicated. Dis-
sociation of the virus was correlated with an increase in the amount of
pentameric capsid subunits (sedimentation coefficient, 12S) (39).
FIG. 6. Competition experiments between viruses C-S8c1 (N17) or
VP1 D17 (D17) during serial passages of a virus mixture, in which
viruses were incubated at pH 7.6 or pH 6.0 prior to each infection. An
initial MOI of 0.1 (0.05 for each virus) was used for the each infection.
Approximate percentages of competing genomes during serial pas-
sages are represented. Passage 0 denotes the initial mixture of viruses.
The proportions of A (in VP1 N17) and G (in VP1 D17) at position
3256 were determined by nucleotide sequencing as described in Ma-
terials and Methods. The average proportions of viral genomes found
in three independent competition experiments are represented.
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ative to C-S8c1, a moderate increase in resistance to virus
inactivation at 42 or 50°C was observed for mutant VP1 N17D
(Fig. 7). The t50 values (calculated as the time in minutes value
leading to a 50% loss of infectivity) derived from these data
were 20 min for C-S8c1 and 41 min for VP1 17D at 42°C and
17.7 min for C-S8c1 and 24.7 min for VP1 17D at 50°C. These
experiments confirmed that amino acid substitution VP1 N17D
also confers some increase in the resistance of FMDV to ther-
mal inactivation.
DISCUSSION
A few FMDV mutants with altered acid sensitivity have been
described. We recently showed that mutations in structural
proteins can reduce FMDV stability at acidic pH (35). An
FMDV mutant with increased resistance against acid inactiva-
tion has also been described (54) but not fully characterized. In
addition, the rational introduction of a charge reversal muta-
tion in the FMDV capsid led to impaired dissociation of the
nucleic acid-free capsid under acidic conditions (19). In the
present study, type C FMDV mutants (named m1 to m6) with
increased resistance to acid-induced inactivation were isolated
from a viral population after in vitro incubation at pH 6.0. The
selection frequency of these mutants—2.9 105—was similar
to that reported for FMDV monoclonal antibody resistant
mutants (36), but it was 4 orders of magnitude lower than that
reported for FMDV mutants with increased capsid lability
selected by NH4Cl treatment (10
1) (35). This lower fre-
quency of acid-resistant mutants could in principle be due to a
fitness loss related to modifications of the acid-dependent un-
coating mechanism, as suggested by the small plaque pheno-
type reported for type A acid resistant FMDVs (54). However,
viruses m1 to m6 displayed plaque size and growth kinetics
similar to those of the C-S8c1 parental virus (data not shown).
All mutants with increased resistance to acid inactivation iso-
lated in the present study carried a common nucleotide sub-
stitution responsible for amino acid replacement VP1 N17D.
Introduction of this replacement into an infectious clone was
sufficient to confer an increase in the resistance to acid-in-
duced inactivation in the viruses recovered. Replacement in
mutant VP1 N17D also conferred a selective advantage rela-
tive to the parental C-S8c1 virus in mixed-serial infections in
which viruses were incubated at pH 6.0 prior to infection.
When this experiment was performed at pH 7.6, no alteration
in the proportion of the parental and the mutant residues was
observed. This result indicates that the relatively low mutant
frequency of acid-resistant variants in FMDV populations may
not be due to a substantially reduced biological fitness.
Amino acid replacement VP1 N17D is located at the N
terminus of VP1 on the inner surface of FMDV capsid. This is
a nearly isosteric replacement (since the amide and carboxylate
groups have similar volumes and geometries) but introduces an
additional negative charge per capsid protomer (60 additional
charges in the virion). No positively charged groups suitable to
form a short-range coulombic interaction with this newly in-
troduced negatively charged carboxylate are close enough in
the capsid structure. In addition, residue 17 in VP1 is relatively
close to the interpentameric interface, but it neither forms part
of the interpentamer or interprotomer interfaces nor estab-
lishes any short-range interpentameric or interprotomeric in-
teraction that could result in capsid stabilization. The amide
group in VP1 N17 only establishes a hydrogen bond with the
main chain oxygen of VP4 G78 residue of the same protomer
that would disappear upon VP1 N17D mutation, which could
destabilize the interaction between VP1 and the C terminus of
VP4 within the same protomer. In natural FMDV empty par-
ticles, which display an increased resistance to acid disassembly
compared to virions (12), both the N terminus of VP1 and the
C terminus of VP4 are more disordered than in the corre-
sponding virions (13). In the case of type A acid-resistant
FMDV, this mutant displayed four amino acid replacements
(54), one of which was also located at the N terminus of VP1,
but the role of each of these mutations in the acid-resistant
phenotype was not determined. Conformational rearrange-
ments in the N terminus of VP1 have been recently implicated
on the uncoating mechanism of equine rhinitis A virus
(ERAV) (53), an Aphthovirus that shares physicochemical
properties with FMDV such as buoyant density and acid labil-
ity (41, 42). As described for FMDV (see the introduction),
ERAV is internalized within host cell following a clathrin-
dependent pathway, and its uncoating is supposed to occur
within early endosomes (22), where low pH should trigger
capsid disassembly into pentameric subunits via a transient 80S
intermediate particle which has lost the genomic RNA (53).
However, besides similarities between ERAV and FMDV, this
uncoating intermediate has not yet been described for FMDV.
An alternative, nonexclusive model for explaining acid re-
sistance in mutant VP1 N17D is based on the fact that residue
17 of VP1 is located only about 10 Å from the interpentamer
interface and about 15 and 8 Å, respectively, from H140 and
H143 in VP3 of the same protomer. In FMDV, conserved
histidines at these positions (equivalent to residues 141 and
144 in type O or 142 and 145 in type A) may provide a pH-
dependent switch for capsid dissociation in the acidic environ-
FIG. 7. The single amino acid replacement N17D in VP1 increases
FMDV resistance to thermal inactivation. Equal PFU amounts of the
different viruses were incubated at 42 or 50°C, and the remaining
infectivity in viral samples was determined by plaque assay. Each point
corresponds to the average of three independent experiments.
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ment of the endosome; the protonated histidines could estab-
lish an electrostatic repulsion with the dipole of an alpha helix
in the neighboring pentamer, facilitating capsid dissociation (1,
19, 55). The introduction of an additional negative charge in
mutant VP1 N17D could partially neutralize the positive
charge of the protonated H143, reducing the interpentamer
repulsion at acidic pH and leading to increased resistance
against acid-induced dissociation into pentamers, as observed
here.
Along this line, it is interesting that the N17D mutation also
led to a somewhat increased resistance against thermal inacti-
vation of the FMDV virion at neutral pH. A previously engi-
neered neutral-to-charged A65H substitution in VP2 at the
interpentameric interfaces in the FMDV capsid led to a simi-
lar, moderate increase in resistance against thermal inactiva-
tion at neutral pH (39). However, while mutants with a sub-
stantially shifted pH-dependent stability (35, 54; the present
study) can be readily isolated from FMDV populations, mu-
tants with a highly increased stability against thermal inactiva-
tion do not appear to be generally present in FMDV quasi-
species (38). In addition, whereas acid inactivation of the
FMDV virion is directly caused by dissociation of the capsid
into pentameric subunits (19; the present study), its thermal
inactivation at moderate temperatures appears to be due to a
conformational change without capsid dissociation, with disso-
ciation occurring only at much longer incubation times (39).
Thus, the mechanisms for the increased resistance against acid
inactivation or thermal inactivation of mutant N17D and other
FMDV mutants may be quite different.
The additional amino acid replacement VP2 F34L found in
mutant m1 (but not in m2 to m6) is located at an internal
capsid position. Mutant m1 showed slightly higher resistance to
acid inactivation than those of the rest of mutants isolated (Fig.
1A), suggesting that this replacement could be responsible for
its slightly increased acid resistance. For ERAV, conforma-
tional rearrangements in the N terminus of VP2 have been also
described in the uncoating intermediate (53).
Five of the six mutants (m1 to m5) displayed an additional
nucleotide mixture at position 2576 responsible for amino acid
replacement VP3 D9V. This position has been involved in
interprotomer interactions and a salt bridge with VP1 K109
(40), which should be disrupted upon substitution. Amino acid
replacements at this position have been also described in vi-
ruses recovered from persistent cell culture infections (16, 24,
52). The proportion of the nucleotide substitution leading to
VP3 D9V was increased after a second acid treatment (data
not shown), suggesting that this additional replacement could
be related to an increase in acid resistance. However, virus m6,
which lacks VP3 D9V substitution (Table 1), showed a degree
of resistance to acid inactivation similar to that of mutants m2
to m5, which carried this mutation at different proportions
(Fig. 1). Even when further experiments are required to de-
termine the biological effect of replacement VP3 D9V, an
alternative possibility is that this mutation might compensate
for some detrimental effect of the replacement VP1 N17D.
Indeed, the selection of compensatory mutations in response
to amino acid replacements that alter FMDV capsid stability
has been previously documented (40).
Enhanced resistance to acid inactivation correlated with an
increase in the sensitivity of these mutants to drugs that raise
endosomal pH, such as NH4Cl and ConA. This effect is oppo-
site to that previously shown for mutants with increased capsid
lability that were resistant to these drugs (35). These observa-
tions confirm that resistance to in vitro acid inactivation is
related to a lower pH requirement for productive uncoating
within host cells. In this way, the acid-resistant mutants de-
scribed here extend the spectrum of FMDV variants, including
pH50 values ranging from 6.95 for mutant c2 (35) to 6.07 for
mutant m1. These results further illustrate the adaptive flexi-
bility of viral quasispecies to external changes, in this case
alterations associated with pH variations.
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